skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 44,666  for All Library Resources

Sorted by: Sorted by: RelevanceOr hit Enter to replace sort method
Results 1 2 3 4 5 next page
Show only
Refined by: subject: Oncology remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
UALCAN: An update to the integrated cancer data analysis platform
UALCAN: An update to the integrated cancer data analysis platform
Material Type:
Article 		Add to My Research

UALCAN: An update to the integrated cancer data analysis platform

Neoplasia (New York, N.Y.), 2022-03, Vol.25, p.18-27 [Peer Reviewed Journal]

2022 ;Copyright © 2022. Published by Elsevier Inc. ;2022 The Authors. Published by Elsevier Inc. 2022 ;ISSN: 1476-5586 ;ISSN: 1522-8002 ;EISSN: 1476-5586 ;DOI: 10.1016/j.neo.2022.01.001 ;PMID: 35078134

Full text available

Citations Cited by
2
A Comprehensive Immunologic Portrait of Triple-Negative Breast Cancer
A Comprehensive Immunologic Portrait of Triple-Negative Breast Cancer
Material Type:
Article 		Add to My Research

A Comprehensive Immunologic Portrait of Triple-Negative Breast Cancer

Translational oncology, 2018-04, Vol.11 (2), p.311-329 [Peer Reviewed Journal]

2018 ;Copyright © 2018. Published by Elsevier Inc. ;2018 The Authors. Published by Elsevier Inc. on behalf of Neoplasia Press, Inc. 2018 ;ISSN: 1936-5233 ;EISSN: 1936-5233 ;DOI: 10.1016/j.tranon.2018.01.011 ;PMID: 29413765

Full text available

Citations Cited by
3
m1A Regulated Genes Modulate PI3K/AKT/mTOR and ErbB Pathways in Gastrointestinal Cancer
m1A Regulated Genes Modulate PI3K/AKT/mTOR and ErbB Pathways in Gastrointestinal Cancer
Material Type:
Article 		Add to My Research

m1A Regulated Genes Modulate PI3K/AKT/mTOR and ErbB Pathways in Gastrointestinal Cancer

Translational oncology, 2019-10, Vol.12 (10), p.1323-1333 [Peer Reviewed Journal]

2019 The Authors ;Copyright © 2019 The Authors. Published by Elsevier Inc. All rights reserved. ;2019 The Authors 2019 ;ISSN: 1936-5233 ;EISSN: 1936-5233 ;DOI: 10.1016/j.tranon.2019.06.007 ;PMID: 31352195

Full text available

Citations Cited by
4
A Phase Ib Study of Pembrolizumab as Second-Line Therapy for Chinese Patients With Advanced or Metastatic Melanoma (KEYNOTE-151)
A Phase Ib Study of Pembrolizumab as Second-Line Therapy for Chinese Patients With Advanced or Metastatic Melanoma (KEYNOTE-151)
Material Type:
Article 		Add to My Research

A Phase Ib Study of Pembrolizumab as Second-Line Therapy for Chinese Patients With Advanced or Metastatic Melanoma (KEYNOTE-151)

Translational oncology, 2019-06, Vol.12 (6), p.828-835 [Peer Reviewed Journal]

2019 ;Copyright © 2019 The Authors. Published by Elsevier Inc. All rights reserved. ;2019 The Authors. Published by Elsevier Inc. on behalf of Neoplasia Press, Inc. 2019 ;ISSN: 1936-5233 ;EISSN: 1936-5233 ;DOI: 10.1016/j.tranon.2019.02.007 ;PMID: 30981094

Full text available

Citations Cited by
5
Quantitative Biomarkers for Prediction of Epidermal Growth Factor Receptor Mutation in Non-Small Cell Lung Cancer
Quantitative Biomarkers for Prediction of Epidermal Growth Factor Receptor Mutation in Non-Small Cell Lung Cancer
Material Type:
Article 		Add to My Research

Quantitative Biomarkers for Prediction of Epidermal Growth Factor Receptor Mutation in Non-Small Cell Lung Cancer

Translational oncology, 2018-02, Vol.11 (1), p.94-101 [Peer Reviewed Journal]

2017 The Authors ;Copyright © 2017 The Authors. Published by Elsevier Inc. All rights reserved. ;2017 The Authors 2017 ;ISSN: 1936-5233 ;EISSN: 1936-5233 ;DOI: 10.1016/j.tranon.2017.10.012 ;PMID: 29216508

Full text available

Citations Cited by
6
A CRISPR Test for Detection of Circulating Nuclei Acids
A CRISPR Test for Detection of Circulating Nuclei Acids
Material Type:
Article 		Add to My Research

A CRISPR Test for Detection of Circulating Nuclei Acids

Translational oncology, 2019-12, Vol.12 (12), p.1566-1573 [Peer Reviewed Journal]

2019 The Authors ;Copyright © 2019 The Authors. Published by Elsevier Inc. All rights reserved. ;2019 The Authors 2019 ;ISSN: 1936-5233 ;EISSN: 1936-5233 ;DOI: 10.1016/j.tranon.2019.08.011 ;PMID: 31634698

Full text available

Citations Cited by
7
Somatic copy number alterations are associated with EGFR amplification and shortened survival in patients with primary glioblastoma
Somatic copy number alterations are associated with EGFR amplification and shortened survival in patients with primary glioblastoma
Material Type:
Article 		Add to My Research

Somatic copy number alterations are associated with EGFR amplification and shortened survival in patients with primary glioblastoma

Neoplasia (New York, N.Y.), 2020-01, Vol.22 (1), p.10-21 [Peer Reviewed Journal]

2019 Neoplasia Press, Inc. ;Copyright © 2019 Neoplasia Press, Inc. Published by Elsevier Inc. All rights reserved. ;2019 Neoplasia Press, Inc. 2019 ;ISSN: 1476-5586 ;ISSN: 1522-8002 ;EISSN: 1476-5586 ;DOI: 10.1016/j.neo.2019.09.001 ;PMID: 31751860

Full text available

Citations Cited by
8
The paradox of radiation and T cells in tumors
The paradox of radiation and T cells in tumors
Material Type:
Article 		Add to My Research

The paradox of radiation and T cells in tumors

Neoplasia (New York, N.Y.), 2022-09, Vol.31, p.100808-100808, Article 100808 [Peer Reviewed Journal]

2022 ;Copyright © 2022. Published by Elsevier Inc. ;2022 The Authors. Published by Elsevier Inc. 2022 ;ISSN: 1476-5586 ;ISSN: 1522-8002 ;EISSN: 1476-5586 ;DOI: 10.1016/j.neo.2022.100808 ;PMID: 35691060

Full text available

Citations Cited by
9
Pamiparib is a potent and selective PARP inhibitor with unique potential for the treatment of brain tumor
Pamiparib is a potent and selective PARP inhibitor with unique potential for the treatment of brain tumor
Material Type:
Article 		Add to My Research

Pamiparib is a potent and selective PARP inhibitor with unique potential for the treatment of brain tumor

Neoplasia (New York, N.Y.), 2020-09, Vol.22 (9), p.431-440 [Peer Reviewed Journal]

2020 The Authors ;Copyright © 2020 The Authors. Published by Elsevier Inc. All rights reserved. ;2020 The Authors 2020 ;ISSN: 1476-5586 ;ISSN: 1522-8002 ;EISSN: 1476-5586 ;DOI: 10.1016/j.neo.2020.06.009 ;PMID: 32652442

Full text available

Citations Cited by
10
The Cell Cycle Inhibitors p21Cip1 and p27Kip1 Control Proliferation but Enhance DNA Damage Resistance of Glioma Stem Cells
The Cell Cycle Inhibitors p21Cip1 and p27Kip1 Control Proliferation but Enhance DNA Damage Resistance of Glioma Stem Cells
Material Type:
Article 		Add to My Research

The Cell Cycle Inhibitors p21Cip1 and p27Kip1 Control Proliferation but Enhance DNA Damage Resistance of Glioma Stem Cells

Neoplasia (New York, N.Y.), 2017-07, Vol.19 (7), p.519-529 [Peer Reviewed Journal]

The Authors ;2017 The Authors ;2017 The Authors 2017 ;ISSN: 1476-5586 ;ISSN: 1522-8002 ;EISSN: 1476-5586 ;DOI: 10.1016/j.neo.2017.04.001 ;PMID: 28582703

Full text available

Citations Cited by
11
Mirvetuximab Soravtansine (IMGN853), a Folate Receptor Alpha–Targeting Antibody-Drug Conjugate, Potentiates the Activity of Standard of Care Therapeutics in Ovarian Cancer Models1
Mirvetuximab Soravtansine (IMGN853), a Folate Receptor Alpha–Targeting Antibody-Drug Conjugate, Potentiates the Activity of Standard of Care Therapeutics in Ovarian Cancer Models1
Material Type:
Article 		Add to My Research

Mirvetuximab Soravtansine (IMGN853), a Folate Receptor Alpha–Targeting Antibody-Drug Conjugate, Potentiates the Activity of Standard of Care Therapeutics in Ovarian Cancer Models1

Neoplasia (New York, N.Y.), 2016-12, Vol.18 (12), p.775-784 [Peer Reviewed Journal]

2016 The Authors 2016 ;ISSN: 1522-8002 ;EISSN: 1476-5586 ;DOI: 10.1016/j.neo.2016.11.002 ;PMID: 27889646

Full text available

Citations Cited by
12
Tumor-associated neutrophils suppress antitumor immunity of NK cells through the PD-L1/PD-1 axis
Tumor-associated neutrophils suppress antitumor immunity of NK cells through the PD-L1/PD-1 axis
Material Type:
Article 		Add to My Research

Tumor-associated neutrophils suppress antitumor immunity of NK cells through the PD-L1/PD-1 axis

Translational oncology, 2020-10, Vol.13 (10), p.100825-100825, Article 100825 [Peer Reviewed Journal]

2020 The Authors ;Copyright © 2020 The Authors. Published by Elsevier Inc. All rights reserved. ;2020 The Authors 2020 ;ISSN: 1936-5233 ;EISSN: 1936-5233 ;DOI: 10.1016/j.tranon.2020.100825 ;PMID: 32698059

Full text available

Citations Cited by
13
RRx-001 Acts as a Dual Small Molecule Checkpoint Inhibitor by Downregulating CD47 on Cancer Cells and SIRP-α on Monocytes/Macrophages
RRx-001 Acts as a Dual Small Molecule Checkpoint Inhibitor by Downregulating CD47 on Cancer Cells and SIRP-α on Monocytes/Macrophages
Material Type:
Article 		Add to My Research

RRx-001 Acts as a Dual Small Molecule Checkpoint Inhibitor by Downregulating CD47 on Cancer Cells and SIRP-α on Monocytes/Macrophages

Translational oncology, 2019-04, Vol.12 (4), p.626-632 [Peer Reviewed Journal]

2018 ;Copyright © 2018. Published by Elsevier Inc. ;2018 Published by Elsevier Inc. on behalf of Neoplasia Press, Inc. 2018 ;ISSN: 1936-5233 ;EISSN: 1936-5233 ;DOI: 10.1016/j.tranon.2018.12.001 ;PMID: 30738349

Full text available

Citations Cited by
14
Circulating Exosomal miR-17-5p and miR-92a-3p Predict Pathologic Stage and Grade of Colorectal Cancer
Circulating Exosomal miR-17-5p and miR-92a-3p Predict Pathologic Stage and Grade of Colorectal Cancer
Material Type:
Article 		Add to My Research

Circulating Exosomal miR-17-5p and miR-92a-3p Predict Pathologic Stage and Grade of Colorectal Cancer

Translational oncology, 2018-04, Vol.11 (2), p.221-232 [Peer Reviewed Journal]

2018 The Authors ;Copyright © 2018 The Authors. Published by Elsevier Inc. All rights reserved. ;2018 The Authors 2018 ;ISSN: 1936-5233 ;EISSN: 1936-5233 ;DOI: 10.1016/j.tranon.2017.12.012 ;PMID: 29367070

Full text available

Citations Cited by
15
Liver X Receptor Agonism Sensitizes a Subset of Hepatocellular Carcinoma to Sorafenib by Dual-Inhibiting MET and EGFR
Liver X Receptor Agonism Sensitizes a Subset of Hepatocellular Carcinoma to Sorafenib by Dual-Inhibiting MET and EGFR
Material Type:
Article 		Add to My Research

Liver X Receptor Agonism Sensitizes a Subset of Hepatocellular Carcinoma to Sorafenib by Dual-Inhibiting MET and EGFR

Neoplasia (New York, N.Y.), 2020-01, Vol.22 (1), p.1-9 [Peer Reviewed Journal]

2019 The Authors ;Copyright © 2019 The Authors. Published by Elsevier Inc. All rights reserved. ;2019 The Authors 2019 ;ISSN: 1476-5586 ;ISSN: 1522-8002 ;EISSN: 1476-5586 ;DOI: 10.1016/j.neo.2019.08.002 ;PMID: 31751859

Full text available

Citations Cited by
16
2D and 3D CT Radiomics Features Prognostic Performance Comparison in Non-Small Cell Lung Cancer
2D and 3D CT Radiomics Features Prognostic Performance Comparison in Non-Small Cell Lung Cancer
Material Type:
Article 		Add to My Research

2D and 3D CT Radiomics Features Prognostic Performance Comparison in Non-Small Cell Lung Cancer

Translational oncology, 2017-12, Vol.10 (6), p.886-894 [Peer Reviewed Journal]

2017 The Authors ;Copyright © 2017 The Authors. Published by Elsevier Inc. All rights reserved. ;2017 The Authors 2017 ;ISSN: 1936-5233 ;EISSN: 1936-5233 ;DOI: 10.1016/j.tranon.2017.08.007 ;PMID: 28930698

Full text available

Citations Cited by
17
Diagnosis of Distant Metastasis of Lung Cancer: Based on Clinical and Radiomic Features
Diagnosis of Distant Metastasis of Lung Cancer: Based on Clinical and Radiomic Features
Material Type:
Article 		Add to My Research

Diagnosis of Distant Metastasis of Lung Cancer: Based on Clinical and Radiomic Features

Translational oncology, 2018-02, Vol.11 (1), p.31-36 [Peer Reviewed Journal]

2017 ;Copyright © 2017. Published by Elsevier Inc. ;2017 Published by Elsevier Inc. on behalf of Neoplasia Press, Inc. 2017 ;ISSN: 1936-5233 ;EISSN: 1936-5233 ;DOI: 10.1016/j.tranon.2017.10.010 ;PMID: 29156383

Full text available

Citations Cited by
18
Frailty as a Predictor of Complications and Transplant-Free Survival after Transarterial Chemoembolization of Hepatocellular Carcinoma
Frailty as a Predictor of Complications and Transplant-Free Survival after Transarterial Chemoembolization of Hepatocellular Carcinoma
Material Type:
Article 		Add to My Research

Frailty as a Predictor of Complications and Transplant-Free Survival after Transarterial Chemoembolization of Hepatocellular Carcinoma

Journal of clinical interventional radiology isvir, 2023-04, Vol.7 (1), p.027-033 [Peer Reviewed Journal]

Indian Society of Vascular and Interventional Radiology. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. ;ISSN: 2456-4869 ;EISSN: 2456-4869 ;DOI: 10.1055/s-0042-1745775

Full text available

Citations Cited by
19
Targeting histone deacetylase SIRT1 selectively eradicates EGFR TKI-resistant cancer stem cells via regulation of mitochondrial oxidative phosphorylation in lung adenocarcinoma
Targeting histone deacetylase SIRT1 selectively eradicates EGFR TKI-resistant cancer stem cells via regulation of mitochondrial oxidative phosphorylation in lung adenocarcinoma
Material Type:
Article 		Add to My Research

Targeting histone deacetylase SIRT1 selectively eradicates EGFR TKI-resistant cancer stem cells via regulation of mitochondrial oxidative phosphorylation in lung adenocarcinoma

Neoplasia (New York, N.Y.), 2020-01, Vol.22 (1), p.33-46 [Peer Reviewed Journal]

2019 Neoplasia Press, Inc. ;Copyright © 2019 Neoplasia Press, Inc. Published by Elsevier Inc. All rights reserved. ;2019 Neoplasia Press, Inc. 2019 ;ISSN: 1476-5586 ;ISSN: 1522-8002 ;EISSN: 1476-5586 ;DOI: 10.1016/j.neo.2019.10.006 ;PMID: 31765940

Full text available

Citations Cited by
20
Monitoring Breast Cancer Response to Neoadjuvant Chemotherapy Using Ultrasound Strain Elastography
Monitoring Breast Cancer Response to Neoadjuvant Chemotherapy Using Ultrasound Strain Elastography
Material Type:
Article 		Add to My Research

Monitoring Breast Cancer Response to Neoadjuvant Chemotherapy Using Ultrasound Strain Elastography

Translational oncology, 2019-09, Vol.12 (9), p.1177-1184 [Peer Reviewed Journal]

2019 The Authors ;Copyright © 2019 The Authors. Published by Elsevier Inc. All rights reserved. ;2019 The Authors 2019 ;ISSN: 1936-5233 ;EISSN: 1936-5233 ;DOI: 10.1016/j.tranon.2019.05.004 ;PMID: 31226518

Full text available

Citations Cited by

Results 1 - 20 of 44,666  for All Library Resources

Sorted by: Sorted by: RelevanceOr hit Enter to replace sort method
Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (44,601)

Refine My Results

Creation Date 

From To
Refine
  1. Before 2008  (28)
  2. 2008 To 2011  (6,741)
  3. 2012 To 2015  (10,873)
  4. 2016 To 2020  (16,707)
  5. After 2020  (10,318)
  6. More options open sub menu

Subject 

  1. Original Article  (41,599)
  2. Science & Technology  (39,947)
  3. Life Sciences & Biomedicine  (39,946)
  4. Medicine & Public Health  (39,697)
  5. Medicine  (39,609)
  6. Humans  (29,224)
  7. Female  (21,170)
  8. Male  (20,759)
  9. Middle Aged  (17,197)
  10. Aged  (14,167)
  11. Adult  (12,964)
  12. Cancer Research  (12,428)
  13. Hematology  (10,735)
  14. Original  (9,773)
  15. Cancer  (7,601)
  16. Retrospective Studies  (7,198)
  17. Biochemistry  (6,319)
  18. Patients  (6,128)
  19. Gastroenterology  (5,921)
  20. More options open sub menu

Language 

  1. English  (44,589)
  2. Japanese  (5,051)
  3. French  (73)
  4. Norwegian  (41)
  5. German  (7)
  6. Russian  (3)
  7. Portuguese  (3)
  8. Italian  (1)
  9. Korean  (1)
  10. Dutch  (1)
  11. More options open sub menu
INSPIRE LIBRARY - TON DUC THANG UNIVERSITY (84-028) 37 755 057 Feedback
19 Nguyen Huu Tho St. Dist.7, HCM thuvien@tdtu.edu.vn

Copyright © 2017 INSPIRE LIBRARY - TON DUC THANG UNIVERSITY

Searching Remote Databases, Please Wait